MedPath

Arvexone

Brand Name: Arvexone

Generic Name: Ceftriaxone As Sodium

Active
Registration Number

DRP-2060-01

Dosage Form

Powder For Injection

Issuance Date

March 31, 2022

Expiry Date

July 16, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1 gram
PackagingType I Glass vial with rubber stopper and green flip off seal

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Cephalosporins (Third Generation)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Ceftriaxone As SodiumActive
Monograph: ceftriaxone as sodium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform